We are currently conducting advanced tests for the GAD65 marker using line blot technology.
GAD65, or Glutamic Acid Decarboxylase 65, is an essential enzyme involved in neurotransmitter production and plays a crucial role in autoimmune responses. It is a key marker for the early detection of autoimmune diseases, particularly type 1 diabetes and certain neurological disorders.
🧐 By testing for GAD65 antibodies, we can identify autoimmune activity against insulin-producing beta cells, providing critical insight for early diagnosis and patient care. Our use of line blot technology ensures high specificity and reliability in detecting this important marker.
Stay tuned for more updates as we continue our work in delivering cutting-edge solutions for autoimmune disease detection!